Medicare Enrolled
Dr. Jennifer Weed, CRNP
Physician Assistant · Abington, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Weed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Weed
Dr. Jennifer Weed is a physician assistant in Abington, PA, with 7 years of NPI registration. Based on federal Medicare data, Dr. Weed performed 6,447 Medicare services across 1,599 unique beneficiaries.
Between the years covered by Open Payments, Dr. Weed received a total of $9,728 from 49 pharmaceutical and/or device companies across 508 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Weed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 7 years in practice
▲ Top 1% volume in PA
$9,728 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,447
Medicare services
Top 1% in PA for physician assistant
1,599
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~921 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,594 | $86 | $652 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
1,477 | $4 | $27 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
1,167 | $61 | $300 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
724 | $112 | $575 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
319 | $44 | $205 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
283 | $153 | $780 |
| Anti-nausea injection (ondansetron/Zofran) | 188 | $0 | $30 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
187 | $242 | $1,000 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
127 | $13 | $77 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
104 | $0 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
95 | $52 | $459 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
55 | $121 | $912 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
44 | $46 | $392 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
44 | $14 | $116 |
| Electrocardiogram, 1 to 3 leads A test that records the electrical activity of the heart using one to three electrodes placed on the body. |
39 | $5 | $32 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
4.5% medium
94.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,728
Total received (2021-2024)
Avg $2,432/year across 4 years
Top 2% in PA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
508
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,728 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,674
2023
$2,413
2022
$2,410
2021
$2,230
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SCILEX PHARMACEUTICALS INC.
$489
Collegium Pharmaceutical, Inc.
$398
Abbott Laboratories
$298
Vertos Medical, Inc.
$244
Valinor Pharma, LLC
$171
ABBVIE INC.
$144
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$135
IBSA Pharma Inc.
$118
Lilly USA, LLC
$99
Averitas Pharma Inc.
$87
Teva Pharmaceuticals USA, Inc.
$74
PFIZER INC.
$68
Stryker Corporation
$62
Boston Scientific Corporation
$56
Avanos Medical
$43
VERTEX PHARMACEUTICALS INCORPORATED
$35
Zimmer Biomet Holdings, Inc.
$34
Lundbeck LLC
$29
Neurocrine Biosciences, Inc.
$24
Saluda Medical Americas, Inc.
$24
Azurity Pharmaceuticals, Inc.
$16
Medtronic, Inc.
$14
PROTEGA PHARMACEUTIALS INC
$13
Top 3 companies account for 44.3% of 2024 payments
All-time payments by company (2021-2024) ›
Collegium Pharmaceutical, Inc.
$1,746
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,118
Abbott Laboratories
$1,010
Scilex Pharmaceuticals Inc.
$672
SCILEX PHARMACEUTICALS INC.
$545
Vertos Medical, Inc.
$538
ABBVIE INC.
$381
Boston Scientific Corporation
$360
Lilly USA, LLC
$283
IBSA Pharma Inc.
$281
BioDelivery Sciences International, Inc.
$230
Valinor Pharma, LLC
$226
Averitas Pharma Inc.
$222
RedHill Biopharma Inc.
$184
Nevro Corp.
$173
PFIZER INC.
$154
BOSTON SCIENTIFIC CORPORATION
$122
Forte Bio-Pharma LLC
$119
Teva Pharmaceuticals USA, Inc.
$113
Allergan, Inc.
$113
GRT US Holding, Inc.
$112
Biohaven Pharmaceutical Holding Company Ltd.
$92
Almatica Pharma LLC
$83
Medtronic, Inc.
$65
Azurity Pharmaceuticals, Inc.
$64
Stryker Corporation
$62
Kowa Pharmaceuticals America, Inc.
$52
ARBOR PHARMACEUTICALS, INC.
$45
Avanos Medical
$43
Nalu Medical, Inc.
$41
FORTE BIO-PHARMA LLC
$38
MML US, Inc.
$37
VERTEX PHARMACEUTICALS INCORPORATED
$35
Zimmer Biomet Holdings, Inc.
$34
PROTEGA PHARMACEUTIALS INC
$33
Axsome Therapeutics, Inc.
$32
Virtus Pharmaceuticals LLC
$31
Radius Health, Inc.
$31
Lundbeck LLC
$29
Neurocrine Biosciences, Inc.
$24
Saluda Medical Americas, Inc.
$24
Trevena, Inc.
$22
Pacira Pharmaceuticals Incorporated
$21
Amneal Pharmaceuticals LLC
$20
Amgen Inc.
$16
Currax Pharmaceuticals LLC
$14
Horizon Therapeutics plc
$13
Arbor Pharmaceuticals, Inc.
$13
Stimwave Technologies Incorporated
$12
Top 3 companies account for 39.8% of all-time payments
Associated products mentioned in payments ›
AUSTEDO · AXIUM · Aimovig · Austedo XR · BELBUCA · BOTOX · Belbuca · COLOGUARD DNA CAPTURE REAGENTS · ELYXYB - celecoxib · EMGALITY · ETERNA · EXCLAIM · Evoke · Exparel · GENERAL PAIN MANAGEMENT · GENERATOR · GRALISE · Gel-One Cross-linked Hyaluronate · HORIZANT · Horizant · INGREZZA · INTELLIS ADAPTIVESTIM · LACTULOSE · LAMITRODE · LICART · LYVISPAH · Livalo · MILD DEVICE KIT · MOVANTIK · Movantik · NALOCET · NURTEC ODT · Nalu Neurostimulation System · OCTRODE · ONZETRA XSAIL · Octrode SCS Leads · Olinvyk · Omnia · PENTA · PROLATE · Penta SCS Leads · Proclaim IPG · QULIPTA · QUTENZA · Qutenza · RAYOS · RELISTOR · REYVOW · ROXYBOND · ReActiv8 · SPECTRA WAVEWRITER · Seglentis · Senza · StimQ Receiver Stimulator Kit Channel A US w Receiver · Sunosi · Superion · Superion Indirect Decompression System · Tirosint · Tymlos · UBRELVY · VRAYLAR · VYEPTI · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · ZTLido · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for physician assistant in PA.
Geographic Context
Physician assistants within 10 mi
1,295
Per 100K population
150.4
County median income
$111,521
Nearest hospital
JEFFERSON ABINGTON HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Weed is a clinical cardiology specialist, with above-average Medicare volume (top 1% in PA), with low-engagement industry engagement in the top 2% of PA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Weed experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Weed performed 1,594 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Weed receive payments from pharmaceutical companies?
Yes. Dr. Weed received a total of $9,728 from 49 companies across 508 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weed's costs compare to other physician assistants in Abington?
Dr. Weed's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Physician Assistants in Abington
Browse physician assistants in Abington ranked by procedure volume and transparency data.
Highest volume
Top Physician Assistants in PA
Physician assistants ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Physician Assistants in PA
Which PA physician assistants receive the most from drug and device companies.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology